Patients with Low Prostate-Specific Antigen Levels (≤4 ng/ml) Would Benefit from a Twelve-Core Biopsy Protocol for Prostate Cancer Detection

Publisher： Karger

E-ISSN： 1423-0399|78|4|318-322

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.78, Iss.4, 2007-05, pp. : 318-322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should Men with Serum Prostate-Specific Antigen ≤4 ng/ml and Normal Digital Rectal Examination Undergo a Prostate Biopsy?

By  

Oncology, Vol. 70, Iss. 2, 2006-05 ,pp. : 81-89

Karger

Access to resources Recommend Favorite

Metastatic Prostate Cancer in an Asymptomatic Patient with an Initial Prostate-Specific Antigen (PSA) Serum Concentration of 21,380 ng/ml

By  

Oncology Research and Treatment, Vol. 33, Iss. 3, 2010-02 ,pp. : 110-112

Karger

Access to resources Recommend Favorite

Increasing Prostate-Specific Antigen Levels Differently Influence Prostate Cancer Detection Rates of Two Different 12-Core Prostate Biopsy Schemes

By  

Urologia Internationalis, Vol. 91, Iss. 1, 2013-04 ,pp. : 75-80

Karger

Access to resources Recommend Favorite

Comparison of 6- and 12-Core Prostate Biopsy in Taiwanese Men: Impact of Total Prostate-Specific Antigen, Prostate-Specific Antigen Density and Prostate Volume on Prostate Cancer Detection

By  

Urologia Internationalis, Vol. 82, Iss. 3, 2009-05 ,pp. : 270-275

Karger

Access to resources Recommend Favorite

Lowering the PSA Threshold for Prostate Biopsy from 4 to 2.5 ng/ml: Influence on Cancer Characteristics and Number of Men Needed to Biopt

By  

Urologia Internationalis, Vol. 84, Iss. 2, 2010-03 ,pp. : 141-146

Karger

Access to resources Recommend Favorite